We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Nikon Instruments Displays Latest Clinical Pathology Products at AACC 2022

By LabMedica International staff writers
Posted on 27 Jul 2022

Nikon Instruments (Melville, NY, USA) will be displaying its latest clinical pathology products, including digital pathology and remote slide viewing and sharing, at the 2022 AACC Clinical Lab Expo. More...



The Nikon exhibit booth will feature ECLIPSE Ci-E upright microscope with Digital Sight 10 camera alongside the ECLIPSE Ci-L plus upright microscope with DS-Fi3 camera and NIS-Elements L tablet. To meet the demands of clinical laboratory specialists and researchers, Nikon has reviewed all aspects of microscope usability to develop the ECLIPSE Ci series of microscopes, which combines superior functionality with operational ease. The Ci is designed to ensure natural posture while viewing images, sample changing and capturing images. Bright, eco-friendly LED illumination reduces the need for frequent lamp replacement. A variety of accessories are available that support various imaging techniques.

At AACC 2022, Nikon will showcase the NIS-Elements D imaging software and NIS-Elements BR imaging software. The NIS-Elements D software package is intended for photo-documentation, and includes basic measuring and reporting tools. The NIS-Elements BR Microscope imaging software is geared for acquisition and device control for standard research applications, requiring four-dimensional imaging. Developed for standard research applications such as analysis and photodocumentation of fluorescent imaging, NIS-Elements BR features up to four-dimensional acquisition and advanced device control capabilities.

Nikon is also displaying the D-LEDI Fluorescence LED Illumination System, a long-lasting, multi-color light source for fluorescence observation. It is equipped with four LEDs (385 nm, 475 nm, 550 nm and 621 nm) to support commonly used fluorophores in fluorescence applications. The D-LEDI features a natural cooling system without the use of fans. This new design ensures a vibration-free, stable illumination source for all fluorescence imaging needs. Traditional mercury light sources require frequent lamp replacement. The D-LEDI features long-life LEDs (up to 20,000-hours) that eliminate this need.
 

Related Links:
Nikon Instruments 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study design and workflow (Parankusham H, Vanderlip C, Birkenbihl C, et al. A two-stage plasma biomarker algorithm reduces amyloid PET use and the p-Tau217 gray zone. Annals of Clinical and Translational Neurology. Published online October 19, 2026. doi:10.1002/acn3.70560)

Two-Step Blood Testing Approach Reduces Uncertainty in Amyloid Assessment

Blood-based biomarkers offer a more accessible, less expensive way to detect Alzheimer’s-related brain changes than traditional methods such as amyloid-beta positron emission tomography (Aβ-PET).... Read more

Molecular Diagnostics

view channel
Image: Tumor DNA is extracted from a pathology sample, and normal DNA is extracted from the buffy coat. Both samples undergo WGS to generate the patient-specific mutational signature. At each follow-up, ctDNA extracted from plasma undergoes WGS and is analyzed using a patient-derived signature and an artificial intelligence (AI) pattern recognition algorithm. FFPE: formalin fixed, paraffin embedded. (Snuderl M, Smadbeck J, Wilkins R, et al. The Journal of Molecular Diagnostics, 2026. DOI: 10.1016/j.jmoldx.2026.07.003)

Liquid Biopsy Detects Lung Cancer Recurrence Signals Months Before Imaging

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and remains a major cause of cancer-related death. Early-stage tumors are often treated surgically, but recurrence can still occur... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.